A comparative study of two antispasmodic products: Buscopan and NO-Spa.
D000818:Animals; D002086:Butylscopolammonium Bromide / Q000008:administration & dosage / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006168:Guinea Pigs; D007077:Ileal Diseases / Q000188:drug therapy*; D010208:Papaverine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*; D012602:Scopolamine Derivatives / Q000627:therapeutic use*; D013035:Spasm / Q000188:drug therapy*
D010276:Parasympatholytics; D012602:Scopolamine Derivatives; D002086:Butylscopolammonium Bromide; C005317:drotaverin; D010208:Papaverine